These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20445199)

  • 41. University-based science and biotechnology products: defining the boundaries of intellectual property.
    Kesselheim AS; Avorn J
    JAMA; 2005 Feb; 293(7):850-4. PubMed ID: 15713775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Expectation for the drug development activity in academia].
    Inagaki O
    Yakugaku Zasshi; 2013; 133(2):213-9. PubMed ID: 23370516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The rise of micropharma.
    Barden CJ; Weaver DF
    Drug Discov Today; 2010 Feb; 15(3-4):84-7. PubMed ID: 19837185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pursuit of personalized anticancer therapy: leveraging collaboration between academia and the biotech/pharmaceutical industry.
    Buck E; Mulvihill M; Iwata KK
    Mt Sinai J Med; 2010; 77(4):358-65. PubMed ID: 20687181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The future is much closer collaboration between the pharmaceutical industry and academic medical centers.
    Vallance P; Williams P; Dollery C
    Clin Pharmacol Ther; 2010 May; 87(5):525-7. PubMed ID: 20407455
    [No Abstract]   [Full Text] [Related]  

  • 47. Racing to define pharmaceutical R&D external innovation models.
    Wang L; Plump A; Ringel M
    Drug Discov Today; 2015 Mar; 20(3):361-70. PubMed ID: 25448753
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of modern biology and medicine in drug development in academia and industry.
    Blake CA; Barker KL; Sobel BE
    Exp Biol Med (Maywood); 2006 Dec; 231(11):1680-1. PubMed ID: 17138752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. From East to West: a Japanese Pharma perspective on establishing a global research capability.
    Takatani M; Kenny B; Hird N
    Drug Discov Today; 2009 Jun; 14(11-12):611-7. PubMed ID: 19508924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bringing together the academic drug discovery community.
    Slusher BS; Conn PJ; Frye S; Glicksman M; Arkin M
    Nat Rev Drug Discov; 2013 Nov; 12(11):811-2. PubMed ID: 24172316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opportunities and challenges in the discovery of new central nervous system drugs.
    Krause JE; Chenard BL
    Ann N Y Acad Sci; 2008 Nov; 1144():243-50. PubMed ID: 19076381
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Challenges faced by the pharmaceutical industry: training graduates for employment in pharmaceutical R&D.
    Mooney KG
    Eur J Pharm Sci; 2001 Feb; 12(4):353-9. PubMed ID: 11231101
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pharmaceutical industry and research in 2002 and beyond.
    Dutta AS; Garner A
    Drug News Perspect; 2003 Dec; 16(10):637-48. PubMed ID: 14747843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Importance of scientific collaboration in contemporary drug discovery and development: a detailed network analysis.
    Cheng F; Ma Y; Uzzi B; Loscalzo J
    BMC Biol; 2020 Oct; 18(1):138. PubMed ID: 33050894
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The innovative medicines initiative: a European response to the innovation challenge.
    Goldman M
    Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Industry-sponsored clinical research: a double-edged sword.
    Montaner JS; O'Shaughnessy MV; Schechter MT
    Lancet; 2001 Dec; 358(9296):1893-5. PubMed ID: 11741648
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The hunt for a new drug: five views from the inside.
    Mervis J
    Science; 2005 Jul; 309(5735):722. PubMed ID: 16051781
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug discovery dilemma and Cura quartet collaboration.
    Shah S; Federoff HJ
    Drug Discov Today; 2009 Nov; 14(21-22):1006-10. PubMed ID: 19815089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. University - industry collaborations: models, drivers and cultures.
    Ehrismann D; Patel D
    Swiss Med Wkly; 2015; 145():w14086. PubMed ID: 25658854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.